MYOG and Huntington disease: Additionally, HD skeletal muscle shows a denervation-like phenotype, which might be linked to the deregulated HDAC4-myogenin axis (Mielcarek et al., 2015), and HDAC4 is a valid therapeutic target in HD (Mielcarek et al., 2011, 2013).